Family Medicine · Arkansas City, KS
NPI
1053313361
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
510 W Radio Ln
Arkansas City, KS, 67005
Phone (620) 442-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
133 services
Medicare patients, 2024
62
Average age 76
Drug cost, 2024
$1.4M
22,698 prescriptions
Company payments, 2025
$233
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Klaassen was code 99232 (hospital e&m - subsequent), 35 times for 19 patients. In total Paul A Klaassen billed 133 services in 17 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 35 | 19 | $57.96 | $2,029 |
| 99222 Hospital E&M - Initial | Facility | 26 | 25 | $88.63 | $2,304 |
| 99239 Hospital Discharge Management | Facility | 26 | 25 | $84.07 | $2,186 |
By year: 2022 $41K for 557 services; 2023 $20K for 249 services; 2024 $12K for 133 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Klaassen prescribed most often to Medicare patients was Amlodipine Besylate, with 832 prescriptions and refills. In total Paul A Klaassen wrote 22,698 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 832 | 1,446 | 155 | $4,388 |
| Atorvastatin Calcium Generic | 798 | 1,596 | 182 | $5,723 |
| Gabapentin Generic | 673 | 779 | 98 | $8,962 |
| Lisinopril Generic | 634 | 1,134 | 117 | $3,990 |
| Levothyroxine Sodium Generic | 631 | 1,038 | 117 | $4,109 |
| Pantoprazole Sodium Generic | 522 | 746 | 97 | $4,921 |
| Losartan Potassium Generic | 495 | 989 | 110 | $3,875 |
| Potassium Chloride Generic | 489 | 616 | 87 | $6,438 |
| Sertraline Hcl Generic | 460 | 541 | 60 | $3,362 |
| Omeprazole Generic | 453 | 665 | 89 | $3,660 |
| Montelukast Sodium Generic | 435 | 681 | 78 | $3,483 |
| Furosemide Generic | 409 | 506 | 63 | $1,880 |
| Tamsulosin Hcl Generic | 357 | 556 | 66 | $4,341 |
| Metformin Hcl Generic | 341 | 670 | 72 | $1,952 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 323 | 323 | 69 | $7,352 |
Brand drugs: 2,566 claims; generic drugs: 20,034 claims; opioid claims: 824.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Klaassen $233 ($233 in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $62.21.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $62.21 |
| Novo Nordisk Inc NVO | 2 | $43.57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36.34 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $25.37 |
| GlaxoSmithKline, LLC. GSK | 1 | $23.53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $14.59 |
| Amgen Inc. AMGN | 1 | $13.99 |
| Pfizer Inc. PFE | 1 | $13.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.